Zura Bio is a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. The Company has also announced the appointment of Robert Lisicki as Chief Executive Officer, effective April 8, 2024, succeeding Someit Sidhu, M.D.